Strides Pharma Science Limited considered and approved offering for subscription, on a private placement basis, up to 1,500 senior, secured, rated, unlisted, redeemable, Non-Convertible Debentures (NCDs) of face value INR 10,00,000 each aggregating up to INR 1500 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
886.6 INR | -1.14% | +1.12% | +36.55% |
Apr. 30 | Strides Pharma Science Limited Approves Appointment of Ameet P Hariani as Independent Director | CI |
Apr. 09 | Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.55% | 977M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Limited Approves Offering for Subscription Up to 1,500 Senior, Secured, Rated, Unlisted, Redeemable, Non-Convertible Debentures